Diabetes drug shows promise for kidney and heart health in Non-Diabetic patients
NCT ID NCT07344922
First seen Jan 19, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tested whether dapagliflozin, a drug typically used for diabetes, can help people with chronic kidney disease who do not have diabetes. One hundred adults took either the drug or a placebo daily for 12 months. Researchers measured kidney function, anemia markers, and heart health to see if the drug slows disease progression and improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Urology and Nephrology Center, Mansoura University
Al Mansurah, Dakahlia Governorate, 35511, Egypt
Conditions
Explore the condition pages connected to this study.